Femasys (FEMY) Total Debt Growth (1y) (2021 - 2023)
Powered by 
Analysis
Femasys (FEMY) Total Debt Growth (1y) (2021 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.23 Bn | 175.63 Bn | 7.27 Bn | 142.67% |
| 2 | Intuitive Surgical | 127.53 Bn | 122.31 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.08 Bn | 108.26 Bn | 6.34 Bn | -1.59% |
| 4 | Stryker | 105.08 Bn | 101.60 Bn | 4.50 Bn | -9.88% |
| 5 | Boston Scientific | 64.51 Bn | 63.97 Bn | 3.85 Bn | 8.95% |
| 6 | Edwards Lifesciences | 49.91 Bn | 45.66 Bn | 1.35 Bn | 0.12% |
| 7 | Alcon | 33.07 Bn | 31.61 Bn | 1.68 Bn | -9.07% |
| 8 | Dexcom | 32.35 Bn | 30.40 Bn | 830.00 Mn | - |
| 9 | Steris | 20.78 Bn | 20.30 Bn | 684.20 Mn | 12.29% |
| 10 | Femasys | 9.52 Mn | 8.07 Mn | 189,391.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 0.98% |
| Dec 31, 2022 | -21.99% |
| Sep 30, 2022 | -12.56% |
| Jun 30, 2022 | -11.20% |
| Dec 31, 2021 | -77.71% |